FibroBiologics, Inc. Common Stock (FBLG) Earnings
FibroBiologics, Inc. Common Stock is expected to report next earnings on July 30, 2026 (in NaN days), with a consensus EPS estimate of $-0.82. FBLG has beaten EPS estimates in 2 of its last 5 reported quarters (average surprise +5.5% over the last four).
Next earnings
Jul 30, 2026in NaN days
EPS est $-0.82 · Revenue est —
Track record
Beat EPS in 2 of 5 quarters
Avg surprise +5.5% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Apr 30, 2026 | $-1.26 | $-1.33 | -5.6% | — | — |
| Feb 24, 2026 | $-0.09 | $-0.03 | +66.7% | — | — |
| Oct 31, 2025 | $-0.10 | $-0.13 | -30.0% | — | — |
| Jul 31, 2025 | $-0.11 | $-0.12 | -9.1% | — | — |
| Mar 31, 2025 | $-0.10 | $-0.09 | +10.0% | — | — |
| Dec 30, 2023 | — | $-0.34 | — | — | — |
| Jun 29, 2023 | — | $-0.07 | — | — | — |
| Jun 30, 2022 | — | $-0.04 | — | — | — |
| Mar 31, 2022 | — | $-0.04 | — | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.